Biodistribution and targeting properties of iron oxide nanoparticles for treatments of cancer and iron anemia disease

References

• Aguiar, M. F. D. P., J. B. Mamani, T. K. Felix, R. F. Dos Reis, H. R. Da Silva, L. P. Nucci, M. P. Nucci-da-Silva, and F. Gamarra. 2017. “Magnetic Targeting with Superparamagnetic Iron Oxide Nanoparticles for in Vivo Glioma.” Nanotechnology Reviews 6: 449–472. doi:10.1515/ntrev-2016-0101.
   Web of Science ®Google Scholar
• Albornoz, C., and S. E. Jacobo. 2006. “Preparation of a Biocompatible Magnetic Film from an Aqueous Ferrofluid.” Journal of Magnetism and Magnetic Materials 305 (1): 12–15. doi:10.1016/j.jmmm.2005.11.021.
   Web of Science ®Google Scholar
• Al-Jamal, K. T., J. Bai, J. T. W. Wang, A. Protti, P. Southern, L. Bogart, H. Heidari., et al. 2016. “Magnetic Drug Targeting: Preclinical in Vivo Studies, Mathematical Modeling, and Extrapolation to Humans.” Nano Letters 16 (9): 5652–5660. doi:10.1021/acs.nanolett.6b02261.
   PubMed Web of Science ®Google Scholar
• Alwi, R., S. Telenkov, A. Mandelis, T. Leshuk, F. Gu, S. Oladepo, and K. Michaelian. 2012. “Silica-coated Super Paramagnetic Iron Oxide Nanoparticles (SPION) as Biocompatible Contrast Agent in Biomedical Photoacoustics.” Biomedical Optics Express 3 (10): 2500–2509. doi:10.1364/BOE.3.002500.
   PubMed Web of Science ®Google Scholar
• Arami, H., A. Khandhar, D. Liggitt, and K. M. Krishnan. 2015. “In Vivo Delivery, Pharmacokinetics, Biodistribution And Toxicity of Iron Oxide Nanoparticles.” Chemical Society Reviews 44 (23): 8576–8607. doi:10.1039/C5CS00541H.
   PubMed Web of Science ®Google Scholar
• Auerbach, M., and I. Macdougall. 2017. “The Available Intravenous Iron Formulations: History, efficacy, and Toxicology.” Hemadialysis International 21: S83–S92. doi:10.1111/hdi.12560.
   PubMed Web of Science ®Google Scholar
• Azad, B. B., S. R. Banerjee, M. Pullambhatla, S. Lacerda, C. A. Foss, Y. Wang, R. Ivkov, and M. G. Pomper. 2015. “Evaluation of a PSMA-targeted BNF Nanoparticle Construct.” Nanoscale 7 (10): 4432–4442. doi:10.1039/C4NR06069E.
   PubMed Web of Science ®Google Scholar
• Azadbakht, B., H. Afarideh, M. Ghannadi-Maragheh, A. Bahrami-Samani, and H. Yousefnia. 2018. “Absorbed Doses in Humans from 188Re-Rituximab in the Free Form and Bound to Superparamagnetic Iron Oxide Nanoparticles: Biodistribution Study in Mice.” Applied Radiation and Isotopes: Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine 131: 96–102.
   PubMed Web of Science ®Google Scholar
• Bachmann, R., R. Conrad, B. Kreft, O. Luzar, W. Block, S. Flacke, D. Pauleit., et al. 2002. “Evaluation of a New Ultrasmall Superparamagnetic Iron Oxide Contrast Agent Clariscan, (NC100150) for MRI of Renal Perfusion: Experimental Study in an Animal Model.” Journal of Magnetic Resonance Imaging 16 (2): 190–195. doi:10.1002/jmri.10149.
   PubMed Web of Science ®Google Scholar
• Baiu, D. C., N. S. Artz, M. R. McElreath, B. D. Menapace, D. Hernando, S. B. Reeder, C. Grüttner, and M. Otto. 2015. High specificity targeting and detection of human neuroblastoma using multifunctional anti-GD2 iron-oxide Nanoparticles. Nanomedicine 10: 2973–2988. doi:10.2217/nnm.15.138.
   PubMed Web of Science ®Google Scholar
• Basly, B., D. Felder-Flesch, P. Perriat, C. Billotey, J. Taleb, G. Pourroy, and S. Begin-Colin. 2010. “Dendronized Iron Oxide Nanoparticles as Contrast Agents for MRI.” Chemical Communications (Cambridge, England) 46 (6): 985–987. doi:10.1039/B920348F.
   PubMed Web of Science ®Google Scholar
• Beaumont, M., B. Lemasson, R. Farion, C. Segebarth, C. Rémy, and E. L. Barbier. 2009. “Characterization of Tumor Angiogenesis in Rat Brain Using Iron-based Vessel Size Index MRI in Combination with Gadolinium-based Dynamic Contrast-enhanced MRI.” Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 29 (10): 1714–1726. doi:10.1038/jcbfm.2009.86.
   PubMed Web of Science ®Google Scholar
• Berry, C. C., S. Wells, S. Charles, G. Aitchison, and A. S. G. Curtis. 2004. “Cell Response to Dextran-derivatised Iron Oxide Nanoparticles Post Internalization.” Biomaterials 25 (23): 5405–5413. doi:10.1016/j.biomaterials.2003.12.046.
   PubMed Web of Science ®Google Scholar
• Bietenbeck, M., A. Florian, C. Faber, U. Sechtem, and A. Yilmaz. 2016. “Remote Magnetic Targeting of Iron Oxide Nanoparticles for Cardiovascular Diagnosis and Therapeutic Drug Delivery: Where are We Now?” International Journal of Nanomedicine 11: 3191–203.
   PubMed Web of Science ®Google Scholar
• Boyer, C., M. R. Whittaker, V. Bulmus, J. Liu, and T. P. Davis. 2010. “The Design and Utility of Polymer-stabilized Iron-oxide Nanoparticles for Nanomedicine Applications.” NPG Asia Materials 2 (1): 23–30. doi:10.1038/asiamat.2010.6.
   Web of Science ®Google Scholar
• Briley-Saebo, K., A. Bjornerud, D. Grant, H. Ahlstrom, T. Berg, and G. M. Kindberg. 2004. “Hepatic Cellular Distribution and Degradation of Iron Oxide Nanoparticles following Single Intravenous Injection in Rats: Implications for Magnetic Resonance Imaging.” Cell and Tissue Research 316 (3): 315–323. doi:10.1007/s00441-004-0884-8.
   PubMed Web of Science ®Google Scholar
• Cai, W., and J. Wan. 2007. “Facile Synthesis of Superparamagnetic Magnetite Nanoparticles in Liquid Polyols.” Journal of Colloid and Interface Science 305 (2): 366–370. doi:10.1016/j.jcis.2006.10.023.
   PubMed Web of Science ®Google Scholar
• Chang, D., M. Lim, J. A. C. M. Goos, R. Qiao, Y. Y. Ng, F. M. Mansfeld, M. Jackson, T. P. Davis, and M. Kavallaris. 2018. “Biologically Targeted Magnetic Hyperthermia: Potential and Limitations.” Frontiers in Pharmacology 9:831. doi:10.3389/fphar.2018.00831.
   PubMed Web of Science ®Google Scholar
• Chauhan, R. P., R. Mathur, G. Singh, N. Bag, S. Singh, K. Chuttani, B. S. H. Kumar, S. K. Agrawal, and A. K. Mishra. 2013a. “Evaluation of Biotinylated Magnetic Nanoparticles for Tumour Imaging.’’ Journal of Materials Science 48: 3913–3925. doi:10.1007/s10853-013-7193-0.
   Web of Science ®Google Scholar
• Chauhan, R. P., R. Mathur, G. Singh, A. Kaul, N. Bag, S. Singh, H. Kumar, M. Patra, and A. K. Mishra. 2013b. “Evaluation of Folate Conjugated Superparamagnetic Iron Oxide Nanoparticles for Scintigraphic/Magnetic Resonance Imaging.” Journal of Biomedical Nanotechnology 9: 323–334. doi:10.1166/jbn.2013.1548.
   PubMed Web of Science ®Google Scholar
• Chen, Y.-W., T.-Y. Liu, P.-H. Chang, P.-H. Hsu, H.-L. Liu, H.-C. Lin, and S.-Y. Chen. 2016. “A Theranostic nrGO@MSN-ION Nanocarrier Developed to Enhance the Combination Effect of Sonodynamic Therapy and Ultrasound Hyperthermia for Treating Tumor.” Nanoscale 8 (25): 12648–12657. doi:10.1039/C5NR07782F.
   PubMed Web of Science ®Google Scholar
• Chertok, B., A. E. David, and V. C. Yang. 2010. “Polyethyleneimine-modified Iron Oxide Nanoparticles for Brain Tumor Drug Delivery Using Magnetic Targeting and Intra-carotid Administration.” Biomaterials 31 (24): 6317–6324. doi:10.1016/j.biomaterials.2010.04.043.
   PubMed Web of Science ®Google Scholar
• Chertok, B., A. E. David, Y. Huang, and V. C. Yang. 2007. “Glioma Selectivity of Magnetically Targeted Nanoparticles: A Role of Abnormal Tumor hydrodynamics.” Journal of Controlled Release: Official Journal of the Controlled Release Society 122 (3): 315–323. doi:10.1016/j.jconrel.2007.05.030.
   PubMed Web of Science ®Google Scholar
• Cole, A. J., A. E. David, J. Wang, C. J. Galban, H. L. Hill, and V. C. Yang. 2011. “Polyethylene Glycol Modified, Cross-linked Starch-coated Iron Oxide Nanoparticles for Enhanced Magnetic Tumor Targeting.” Biomaterials 32 (8): 2183–2193. doi:10.1016/j.biomaterials.2010.11.040.
   PubMed Web of Science ®Google Scholar
• Cui, X., S. Belo, D. Krüger, Y. Yan, R. T. M. de Rosales, M. Jauregui-Osoro, H. Ye., et al. 2014. “Aluminium Hydroxide Stabilised MnFe2O4 and Fe3O4 Nanoparticles as Dual-modality Contrasts Agent for MRI and PET Imaging.” Biomaterials 35 (22): 5840–5846. doi:10.1016/j.biomaterials.2014.04.004.
   PubMed Web of Science ®Google Scholar
• Dias, A. M. G. C., A. Hussain, A. S. Marcos, and A. C. A. Roque. 2011. “A Biotechnological Perspective on the Application of Iron Oxide Magnetic Colloids Modified with Polysaccharides.” Biotechnology Advances 29 (1): 142–155. doi:10.1016/j.biotechadv.2010.10.003.
   PubMed Web of Science ®Google Scholar
• DiMarco, M.,. I. Guilbert, M. Port, C. Robic, P. Couvreur, and C. Dubernet. 2007. “Colloidal Stability of Ultrasmall Superparamagnetic Iron Oxide (USPIO) particles with Different Coatings.” International Journal of Pharmaceutics 331 (2): 197–203. doi:10.1016/j.ijpharm.2006.11.002.
   PubMed Web of Science ®Google Scholar
• Dong, C. N., J. A. Tate, W. C. Kett, J. Batra, E. Demidenko, L. D. Lewis, P. J. Hoopes, T. U. Gerngross, and K. E. Griswold. 2015. “Tumor Cell Targeting by Iron Oxide Nanoparticles Is Dominated by Different Factors in Vitro versus in Vivo.” PLOS One 10 (2): e0115636. doi:10.1371/journal.pone.0115636.
   Web of Science ®Google Scholar
• Edge, D., C. M. Shortt, O. L. Gobbo, S. Teughels, A. Prina-Mello, Y. Volkov, P. MacEneaney, M. W. Radomski, and F. Markos. 2016. “Pharmacokinetics and Bio-distribution of Novel Super Paramagnetic Iron Oxide Nanoparticles (SPIONs) in the Anaesthetized Pig.” Clinical and Experimental Pharmacology & Physiology 43 (3): 319–326. doi:10.1111/1440-1681.12533.
   PubMed Web of Science ®Google Scholar
• El-Boubbou, K. 2018. “Magnetic Iron Oxide Nanoparticles as Drug Carriers: Preparation, Conjugation and Delivery.” Nanomedicine 13 (8): 929–952. doi:10.2217/nnm-2017-0320.
   Web of Science ®Google Scholar
• Estelrich, J., E. Escribano, J. Queralt, and M. A. Busquets. 2015. “Iron Oxide Nanoparticles for Magnetically-Guided and Magnetically-Responsive Drug Delivery.” International Journal of Molecular Sciences 16: 8070–8101. doi:10.3390/ijms16048070.
   PubMed Web of Science ®Google Scholar
• Estelrich, J., and M. A. Busquets. 2018. “Iron Oxide Nanoparticles in Photothermal Therapy.” Molecules 23 (7): 1567. doi:10.3390/molecules23071567.
   PubMed Web of Science ®Google Scholar
• Fan, C.-H., C.-Y. Ting, H. J. Lin, C. H. Wang, H. L. Liu, T. C. Yen, and C. K. Yeh. 2013. “SPIO-Conjugated, Doxorubicin-Loaded Microbubbles for Concurrent MRI and Focused-Ultrasound Enhanced Brain-tumor Drug Delivery.” Biomaterials 34 (14): 3706–3715. doi:10.1016/j.biomaterials.2013.01.099.
   PubMed Web of Science ®Google Scholar
• Fan, Y., C. Li, F. Li, and D. Chen. 2016. “pH-activated Size Reduction of Large Compound Nanoparticles for in vivo nucleus-targeted drug delivery.” Biomaterials 85: 30–39. doi:10.1016/j.biomaterials.2016.01.057.
   PubMed Web of Science ®Google Scholar
• Fauconnier, N., J. N. Pons, J. Roger, and A. Bee. 1997. “Thiolation of Maghemite Nanoparticles by Dimercaptosuccinic Acid.” Journal of Colloid and Interface Science 194 (2): 427–433. doi:10.1006/jcis.1997.5125.
   PubMed Web of Science ®Google Scholar
• Feng, Q., Y. Liu, J. Huang, K. Chen, J. Huang, and K. Xiao. 2018. “Uptake, Distribution, Clearance, and Toxicity of Iron Oxide Nanoparticles with Different Sizes and Coatings.” Scientific Reports 8 (1): 2082. doi:10.1038/s41598-018-19628-z.
   PubMed Web of Science ®Google Scholar
• Freitas, J., R. M. Branco, I. G. O. Lisboa, T. P. Costa, M. G. N. Campos, M. J. Junior, and R. F. C. Marques. 2015. “Magnetic Nanoparticles Obtained by Homogeneous Coprecipitation Sonochemically Assisted.” Materials Research 18 (suppl 2): 220–224. doi:10.1590/1516-1439.366114.
   Web of Science ®Google Scholar
• Gautier, J., E. Allard-Vannier, K. Hervé-Aubert, M. Soucé, and I. Chourpa. 2013. “Design Strategies of Hybrid Metallic Nanoparticles for Theragnostic Applications.” Nanotechnology 24 (43): 432002. doi:10.1088/0957-4484/24/43/432002.
   PubMed Web of Science ®Google Scholar
• Geng, Y., P. Dalhaimer, S. Cai, R. Tsai, M. Tewari, T. Minko, and D. E. Discher. 2007. “Shape Effects of Filaments versus Spherical Particles in Flow and Drug Delivery.” Nature Nanotechnology 2 (4): 249–255. doi:10.1038/nnano.2007.70.
   PubMed Web of Science ®Google Scholar
• Giakisikli, G., and A. N. Anthemidis. 2013. “Magnetic Materials as Sorbents for Metal/Metalloid Preconcentration and/or Separation. A Review.” Analytica Chimica Acta 789: 1–16. doi:10.1016/j.aca.2013.04.021.
   PubMed Web of Science ®Google Scholar
• Giustini, A. J., R. Ivkov, and P. J. Hoopes. 2011. “Magnetic Nanoparticle Biodistribution Following Intratumoral Administration.” Nanotechnology 22 (34): 345101. doi:10.1088/0957-4484/22/34/345101.
   PubMed Web of Science ®Google Scholar
• Gobbo, O. L., K. Sjaastad, M. W. Radomski, Y. Volkov, and A. Prina-Mello. 2015. “Magnetic Nanoparticles in Cancer Theranostics.” Theranostics 5 (11): 1249–1263. doi:10.7150/thno.11544.
   PubMed Web of Science ®Google Scholar
• Golombek, S. K., J. N. May, B. Theek, L. Appold, N. Drude, F. Kiessling, and T. Lammers. 2018. “Tumor Targeting via EPR: Strategies to Enhance Patient Responses.” Advanced Drug Delivery Reviews 130: 17–38. doi:10.1016/j.addr.2018.07.007.
   PubMed Web of Science ®Google Scholar
• Groult, H., J. Ruiz-Cabello, A. V. Lechuga-Vieco, J. Mateo, M. Benito, I. Bilbao, M. P. Martínez-Alcázar, J. A. Lopez, J. Vázquez, and F. F. Herranz. 2014. “Phosphatidylcholine-Coated Iron Oxide Nanomicelles for in Vivo Prolonged Circulation Time with an Antibiofouling Protein Corona.” Chemistry - A European Journal 20 (50): 16662–16671. doi:10.1002/chem.201404221.
   PubMed Web of Science ®Google Scholar
• Gu, L., R. H. Fang, M. J. Sailor, and J.-H. Park. 2012. “In Vivo Clearance and Toxicity of Monodisperse Iron Oxide Nanocrystals.” ACS Nano 6 (6): 4947–4954. doi:10.1021/nn300456z.
   PubMed Web of Science ®Google Scholar
• Gupta, A. K., and M. Gupta. 2005. “Synthesis and Surface Engineering of Iron Oxide Nanoparticles for Biomedical applications.” Biomaterials 26 (18): 3995–4021. doi:10.1016/j.biomaterials.2004.10.012.
   PubMed Web of Science ®Google Scholar
• Hadjipanayis, C. G., R. Machaidze, M. Kaluzova, L. Wang, A. J. Schuette, H. Chen, X. Wu, and H. Mao. 2010. “EGFRvIII Antibody-Conjugated Iron Oxide Nanoparticles for Magnetic Resonance Imaging-Guided Convection-Enhanced Delivery and Targeted Therapy of Glioblastoma.” Cancer Research 70 (15): 6303–6312. doi:10.1158/0008-5472.CAN-10-1022.
   PubMed Web of Science ®Google Scholar
• Hayashi, K., M. Nakamura, W. Sakamoto, T. Yogo, H. Miki, S. Ozaki, M. Abe, T. Matsumoto, and K. Ishimura. 2013. “Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment.” Theranostics 3 (6): 366–376. doi:10.7150/thno.5860.
   PubMed Web of Science ®Google Scholar
• Hola, K., Z. Markova, G. Zoppellaro, J. Tucek, and R. Zboril. 2015. “Tailored Functionalization of Iron Oxide Nanoparticles for MRI, drug Delivery, Magnetic Separation and Immobilization of Biosubstances.” Biotechnology Advances 33 (6 Pt 2): 1162–1176. doi:10.1016/j.biotechadv.2015.02.003.
   PubMed Web of Science ®Google Scholar
• Huang, J., L. Bu, J. Xie, K. Chen, Z. Cheng, X. Li, and X. Chen. 2010. “Effects of Nanoparticle Size on Cellular Uptake and Liver MRI with Polyvinylpyrrolidone-Coated Iron Oxide Nanoparticles.’’ ACSNano 4: 7151–7160. doi:10.1021/nn101643u.
   PubMed Web of Science ®Google Scholar
• Huang, W. Y., J.-N. Lin, J.-T. Hsieh, S.-C. Chou, C.-H. Lai, E.-J. Yun, U.-G. Lo, R.-C. Pong, J.-H. Lin, and Y.-H. Lin. 2016. “Nanoparticle Targeting CD44-Positive Cancer Cells for Site-Specific Drug Delivery in Prostate Cancer Therapy’’. ACS Applied Materials & Interfaces 8: 30722−30734. doi:10.1021/acsami.6b10029.
   PubMed Web of Science ®Google Scholar
• Huang, B., H. Zhang, L. Gu, B. Ye, Z. Jian, C. Stary, and X. Xiong. 2017. “Advances in Immunotherapy for Glioblastoma Multiforme.” Journal of Immunology Research 3597613. doi:10.1155/2017/3597613.
   PubMed Web of Science ®Google Scholar
• Jain, T. K., M. K. Reddy, M. A. Morales, D. L. Leslie-Pelecky, and V. Labhasetwar. 2008. “Biodistribution, Clearance, and Biocompatibility of Iron Oxide Magnetic Nanoparticles in Rats.” Molecular Pharmaceutics 5 (2): 316–327. doi:10.1021/mp7001285.
   PubMed Web of Science ®Google Scholar
• Janko, C., S. Dürr, L. Munoz, S. Lyer, R. Chaurio, R. Tietze, S. Löhneysen, C. Schorn, M. Herrmann, and C. Alexiou. 2013. “Magnetic Drug Targeting Reduces the Chemotherapeutic Burden on Circulating Leukocytes.” International Journal of Molecular Sciences 14 (4): 7341–7355. doi:10.3390/ijms14047341.
   PubMed Web of Science ®Google Scholar
• Karimi, Z., L. Karimi, and H. Shokrollahi. 2013. “Nano-magnetic Particles Used in Biomedicine: Core and Coating Materials.” Materials Science & Engineering C, Materials for Biological Applications 33 (5): 2465–2475. doi:10.1016/j.msec.2013.01.045.
   PubMed Web of Science ®Google Scholar
• Khan, H. R., and K. Petrikowski. 2000. “Anisotropic Structural and Magnetic Properties of Arrays of Fe26Ni74 Nanowires Electrodeposited in the Pores of Anodic Alumina.” Journal of Magnetism and Magnetic Materials 215–216: 526–528. doi:10.1016/S0304-8853(00)00209-2.
   Web of Science ®Google Scholar
• Kievit, F. M., and M. Zhang. 2011. “Surface Engineering of Iron Oxide Nanoparticles for Targeted Cancer Therapy.” Accounts of Chemical Research 44 (10): 853–862. doi:10.1021/ar2000277.
   PubMed Web of Science ®Google Scholar
• Kobayashi, H., B. Turkbey, R. Watanabe, and P. L. Choyke. 2014. “Cancer Drug Delivery: Considerations in the Rational Design of Nanosized Bioconjugates.” Bioconjugate Chemistry 25 (12): 2093–2100. doi:10.1021/bc500481x.
   PubMed Web of Science ®Google Scholar
• Kohler, N., C. Sun, J. Wang, and M. Zhang. 2005. “Methotrexate-modified Superparamagnetic Nanoparticles and Their Intracellular Uptake into Human Cancer Cells.” Langmuir: The ACS Journal of Surfaces and Colloids 21 (19): 8858–8864. doi:10.1021/la0503451.
   PubMed Web of Science ®Google Scholar
• Kooi, M. E., V. C. Cappendijk, K. B. J. M. Cleutjens, A. G. H. Kessels, P. J. E. H. M. Kitslaar, M. Borgers, P. M. Frederik, M. J. A. P. Daemen, and J. M. A. van Engelshoven. 2003. “Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by in Vivo Magnetic Resonance Imaging.” Circulation 107 (19): 2453–2458. doi:10.1161/01.CIR.0000068315.98705.CC.
   PubMed Web of Science ®Google Scholar
• Kossatz, S., J. Granke, P. Couleaud, A. Latorre, A. Aires, K. Crosbie-Staunton, R. Ludwig, H. Dahring, V. Ettelt, and A. Lazzao-Carillo. 2015. “Efficient Treatment of Breast Cancer Xenografts with Multifunctionalized Iron Oxide Nanoparticles Combining Magnetic Hyperthermia and anti-cancer Drug Delivery.” Breast Cancer Research 17: 66. doi:10.1186/s13058-015-0576-1.
   PubMed Web of Science ®Google Scholar
• Laurent, S., D. Forge, M. Port, A. Roch, C. Robic, L. Vander Elst, and R. N. Muller. 2008. “Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications.” Chemical Reviews 108 (6): 2064–2110. doi:10.1021/cr068445e.
   PubMed Web of Science ®Google Scholar
• Leal, M. P., C. Munoz-Hernandez, C. Berry, and M. M. L. Garcıa. 2015. “In Vivo Pharmacokinetics of T2 Contrast Agents Based on Iron Oxide Nanoparticles: Optimization of Blood Circulation Times.” RSC Advances 5 (94): 76883–76891. doi:10.1039/C5RA15680G.
   Web of Science ®Google Scholar
• Lewinski, N., H. Graczyk, and M. Riediker. 2013. “Human Inhalation Exposure to Iron Oxide Particles.” BioNanoMaterials 14: 5–23. doi:10.1515/bnm-2013-0007.
   Google Scholar
• Longmire, M., P. L. Choyke, and H. Kobayashi. 2008. “Clearance Properties of Nano-sized Particles and Molecules as Imaging Agents: Considerations and Caveats.” Nanomedicine 3 (5): 703–717. doi:10.2217/17435889.3.5.703.
   PubMed Web of Science ®Google Scholar
• Maeda, H. 2010. “Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects.” Bioconjugate Chemistry 21 (5): 797–802. doi:10.1021/bc100070g.
   PubMed Web of Science ®Google Scholar
• Mahmoudi, M., V. Serpooshan, and S. Laurent. 2011. “Engineered Nanoparticles for Biomolecular imaging.” Nanoscale 3 (8): 3007–3026. doi:10.1039/c1nr10326a.
   PubMed Web of Science ®Google Scholar
• Maier-Hoff, K., F. Ulrich, D. Nestler, H. Niehoff, P. Wust, B. Tiesen, H. Orawa, V. Budach, and A. Jordan. 2011. “Efficacy and Safety of Intratumoral Thermotherapy Using Magnetic Iron-oxide Nanoparticles Combined with External Beam Radiotherapy on Patients with Recurrent Glioblastoma Multiforme.” Journal of Neuro-Oncology 103: 317–324. doi:10.1007/s11060-010-0389-0.
   PubMed Web of Science ®Google Scholar
• Maier-Hoff, K., R. Rothe, R. Scholz, M. J. Van den Bent, M. J. Taphoorn, R. C. Janzer, S. K. Ludwin., et al. 2007. “Intracranial Thermotherapy Using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme.” Journal of Neuro-Oncology 81: 53–60. doi:10.1007/s11060-006-9195-0.
   PubMed Web of Science ®Google Scholar
• Martínez-Mera, I., M. E. Espinosa-Pesqueira, R. Perez-Hernadez, and J. Arenas-Alatorre. 2007. “Synthesis of Magnetite (Fe3O4) Nanoparticles without Surfactants at Room Temperature.” Materials Letters 61 (23–24): 4447–4451. doi:10.1016/j.matlet.2007.02.018.
   Web of Science ®Google Scholar
• Mei, K. C., J. Bai, S. Lorrio, J. T. W. Wang, and K. T. Al-Jamal. 2016. “Investigating the Effect of Tumor Vascularization on Magnetic Targeting in Vivo Using Retrospective Design of Experiment.” Biomaterials 106: 276–285. doi:10.1016/j.biomaterials.2016.08.030.
   PubMed Web of Science ®Google Scholar
• Mejias, R., R. Costo, A. G. Roca, C. F. Arias, S. Veintemillas-Verdaguer, T. Gonzalez-Carreno, M. del Puerto Morales, C. J. Serna, S. Manes, and D. F. Barber. 2008. “Cytokine Adsorption/Release on Uniform Magnetic Nanoparticles for Localized Drug Delivery.” Journal of Controlled Release 130: 168–174. doi:10.1016/j.jconrel.2008.05.028.
   PubMed Web of Science ®Google Scholar
• Mohamaddi, M. R., A. V. Malkovskiy, P. Jothimuthu, K. M. Kim, M. Parekh, M. Inayathullah, Y. Zhuge, and J. Rajadas. 2018. “PEG/Dextran Double Layer Influence Fe Ion Release and Stability of Iron Oxide Nanoparticles.” Scientific Reports 8: 4286. doi:10.1038/s41598-018-22644-8.
   PubMed Web of Science ®Google Scholar
• Monograph of Dexferrum, NDA 40-024/S-022, American regent inc., Shirley, NY 11967, USA.
   Google Scholar
• Monograph of Ferhaeme, AMAG Pharmaceuticals, Inc., Lexington, MA 02421, USA.
   Google Scholar
• Monograph of Ferrlecit 2016. Submission Control No.: 195781, Sanofi-aventis Canada, 2905 Place Louis-R.-Renaud, Laval, Quebec H7V 0A3, Canada.
   Google Scholar
• Monograph of Infed 2017. NDC 0023-6082-10, Allergan USA, Irvine, CA 92612, USA.
   Google Scholar
• Monograph of Venofer 2006. NDA 21-135/S-017, American regent, inc. shirley, NY 11967.
   Google Scholar
• Monograph of Monofer 2017. Pharmacosmos A/S, Roervangsvej 30, DK-4300, Holbaek, Denmark.
   Google Scholar
• Muller, E. K., Grafe, C. Wiekhorst, F. Bergemann, C. Weidner, A. Dutz, S, and J. H. Clement. 2018. “Magnetic Nanoparticles Interact and Pass an in Vitro Co-Culture Blood-Placenta Barrier Model.” Nanomaterials 8: 108. doi:10.3390/nano8020108.
   Web of Science ®Google Scholar
• Musazzi, U. M., B. Santini, F. Selmin, V. Marini, F. Corsi, R. Allevi, A. M. Ferretti, et al. 2017. “Impact of Semi-Solid Formulations on Skin Penetration of Iron Oxide Nanoparticles.” Journal of Nanobiotechnology 15: 14. doi:10.1186/s12951-017-0249-6.
   PubMed Web of Science ®Google Scholar
• Ndong, C., S. Toraya-Brown, K. Kekalo, I. Baker, T. U. Gerngross, S. N. Fiering, and K. E. Griswold. 2015. “Antibody-mediated Targeting of Iron Oxide Nanoparticles to the Folate Receptor Alpha Increases Tumor Cell Association in Vitro and in Vivo.” International Journal of Nanomedicine 10: 2595–2617.
   PubMed Web of Science ®Google Scholar
• Ni, D., C. A. Ferreira, T. E. Barnhart, V. Quach, B. Yu, D. Jiang, W. Wei., et al. 2018. “Magnetic Targeting of Nanotheranostics Enhances Cerenkov Radiation-Induced Photodynamic Therapy.” Journal of the American Chemical Society 140 (44): 14971–14979. doi:10.1021/jacs.8b09374.
   PubMed Web of Science ®Google Scholar
• Obaidat, I. M., B. Issa, and Y. Haik. 2015. “Magnetic Properties of Magnetic Nanoparticles for Efficient Hyperthermia.” Nanomaterials 5: 68–89.
   Web of Science ®Google Scholar
• Osborne, E. A., T. M. Atkins, D. A. Gilbert, S. M. Kauzlarich, K. Liu, and A. Y. Louie. 2012. “Rapid Microwave-Assisted Synthesis of Dextran-Coated Iron Oxide Nanoparticles for Magnetic Resonance Imaging.” Nanotechnology 23 (21): 215602. doi:10.1088/0957-4484/23/21/215602.
   PubMed Web of Science ®Google Scholar
• Osuna, J., D. de Caro, C. Amiens, B. Chaudret, E. Snoeck, M. Respaud, J.-M. Broto, and A. Fert. 1996. “Synthesis, Characterization, and Magnetic Properties of Cobalt Nanoparticles from an Organometallic Precursor.” The Journal of Physical Chemistry 100 (35): 14571–14574. doi:10.1021/jp961086e.
   Web of Science ®Google Scholar
• Parat, A., D. Kryza, F. Degoul, J. Taleb, C. Viallard, M. Janier, A. Garofalo., et al. 2015. “Radiolabeled Dendritic Probes as Tools for High in Vivo Tumor Targeting: Application to Melanoma.” Journal of Materials Chemistry B 3 (12): 2560–2571. doi:10.1039/C5TB00235D.
   PubMed Web of Science ®Google Scholar
• Park, J.-H., G. von Maltzahn, L. Zhang, M. P. Schwartz, E. Ruoslahti, S. N. Bhatia, and M. J. Sailor. 2008. “Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging.” Advanced Materials 20 (9): 1630–1635. doi:10.1002/adma.200800004.
   PubMed Web of Science ®Google Scholar
• Pecharromán, C., T. González-Carreño, and J. E. Iglesias. 1995. “The Infrared Dielectric Properties of Maghemite, γ-Fe2O3, from Reflectance Measurement on Pressed Powders.” Physics and Chemistry of Minerals 22 (1): 21–29. doi:10.1007/BF00202677.
   Web of Science ®Google Scholar
• Peng, X.-H., X. Qian, H. Mao, A. Y. Wang, Z. Chan, S. Nie, and D. M. Shin. 2008. “Targeted Magnetic Iron Oxide Nanoparticles for Tumor Imaging and Therapy.” International Journal of Nanomedicine 3: 311–321.
   PubMed Web of Science ®Google Scholar
• Périgo, E. A., G. Hemery, O. Sandre, D. Ortega, E. Garaio, F. Plazaola, and F. J. Teran. 2015. “Fundamentals and Advances in Magnetic Hyperthermia.” Applied Physics Reviews 2 (4): 041302. doi:10.1063/1.4935688.
   Web of Science ®Google Scholar
• Petros, R. A., and J. M. DeSimone. 2010. “Strategies in the Design of Nanomaprticles for Therapeutic Applications.” Nature Reviews Drug Discovery 9: 615–627. doi:10.1038/nrd2591.
   PubMed Web of Science ®Google Scholar
• Pham, B. T. T., E. K. Colvin, N. T. H. Pham, B. J. Kim, E. S. Fuller, E. A. Moon, R. Barbey., et al. 2018. “Biodistribution and Clearance of Stable Superparamagnetic Maghemite Iron Oxide Nanoparticles in Mice following Intraperitoneal Administration.” International Journal of Molecular Sciences 19 (1): 205. doi:10.3390/ijms19010205.
   Web of Science ®Google Scholar
• Phu, N. D., D. T. Ngo, L. H. Hoang, N. H. Luong, N. Chau, and N. H. Hai. 2011. “Crystallization Process and Magnetic Properties of Amorphous Iron Oxide Nanoparticles.” Journal of Physics D: Applied Physics 44 (34): 345002. doi:10.1088/0022-3727/44/34/345002.
   Web of Science ®Google Scholar
• Qian, X., X. Han, and Y. Chen. 2017. “Insights into the Unique Functionality of Inorganic Micro/nanoparticles for Versatile Ultrasound Theranostics.” Biomaterials 142: 13–30. doi:10.1016/j.biomaterials.2017.07.016.
   PubMed Web of Science ®Google Scholar
• Quan, Q., J. Xie, H. Gao, M. Yang, F. Zhang, G. Liu, X. Lin., et al. 2011. “HSA Coated Iron Oxide Nanoparticles as Drug Delivery Vehicles for Cancer Therapy.” Molecular Pharmaceutics 8 (5): 1669–1676. doi:10.1021/mp200006f.
   PubMed Web of Science ®Google Scholar
• Ramimoghadam, D., S. Bagheri, and S. B. A. Hamid. 2014. “Progress in Electrochemical Synthesis of Magnetic Iron Oxide Nanoparticles.” Journal of Magnetism and Magnetic Materials 368: 207–229. doi:10.1016/j.jmmm.2014.05.015.
   Web of Science ®Google Scholar
• Reddy, L. H., R. K. Sharma, K. Chuttani, A. K. Mishra, and R. S. R. Murthy. 2005. “Influence of Administration Route on Tumor Uptake and Biodistribution of Etoposide Loaded Solid Lipid Nanoparticles in Dalton’s Lymphoma Tumor Bearing Mice.” Journal of Controlled Release 105: 185–198. doi:10.1016/j.jconrel.2005.02.028.
   PubMed Web of Science ®Google Scholar
• Remya, N. S., S. Syama, A. Sabareeswaran, and P. V. Mohanan. 2016. “Toxicity, Toxicokinetics and Biodistribution of Dextran Stabilized Iron Oxide Nanoparticles for Biomedical Applications.” International Journal of Pharmaceutics 511 (1): 586–598. doi:10.1016/j.ijpharm.2016.06.119.
   PubMed Web of Science ®Google Scholar
• Ruiz, A., Y. Hernandez, C. Cabal, E. Gonzalez, S. Veintemillas-Verdaguer, E. Martınezc, and M. P. Morales. 2013. “Biodistribution and Pharmacokinetics of Uniform Magnetite Nanoparticles Chemically Modified with Polyethylene Glycol.” Nanoscale 5 (23): 11400–11408. doi:10.1039/c3nr01412f.
   PubMed Web of Science ®Google Scholar
• Sahoo, Y., A. Goodarzi, M. T. Swihart, T. Y. Ohulchanskyy, N. Kaur, E. P. Furlani, and P. Prasad. 2005. “Aqueous Ferrofluid of Magnetite Nanoparticles: Fluorescence Labeling and Magnetophoretic Control.” The Journal of Physical Chemistry B 109 (9): 3879–3885. doi:10.1021/jp045402y.
   PubMed Web of Science ®Google Scholar
• Sakulkhu, U., M. Mahmoudi, L. Maurizi, G. Coullerez, M. Hofmann-Amtenbrink, M. Vries, M. Motazacker, F. Rezaee, and H. Hofmann. 2015. “Significance of Surface Charge and Shell Material of Superparamagnetic Iron Oxide Nanoparticles (SPIONs) Based Core/Shell Nanoparticles on the Composition of the Protein Corona.” Biomaterials Science 3 (2): 265–278. doi:10.1039/C4BM00264D.
   PubMed Web of Science ®Google Scholar
• Sakulkhu, U., M. Mahmoudi, L. Maurizi, J. Salaklang, and H. Hofmann. 2014. “Protein Corona Composition of Superparamagnetic Iron Oxide Nanoparticles with Various Physico-Chemical Properties and Coatings.” Scientific Reports 4: 5020.doi:10.1038/srep05020.
   PubMed Web of Science ®Google Scholar
• Salazar-Alvarez, G., M. Muhammed, and A. A. Zagorodni. 2006. “Novel Flow Injection Synthesis of Iron Oxide Nanoparticles with Narrow Size Distribution.” Chemical Engineering Science 61 (14): 4625–4633. doi:10.1016/j.ces.2006.02.032.
   Web of Science ®Google Scholar
• Salimi, M., S. Sarkar, S. Fathi, A. M. Alizadeh, R. Saber, F. Moradi, and H. Delavari. 2018. “Biodistribution, Pharmacokinetics, and Toxicity of Dendrimer-coated Iron Oxide Nanoparticles in BAL B/c Mice.” International Journal of Nanomedicine 13: 1483–1493. doi:10.2147/IJN.S157293.
   PubMed Web of Science ®Google Scholar
• Santra, S., C. Kaittanis, and J. M. Perez. 2010. “Cytochrome c Encapsulating Theranostic Nanoparticles: A Novel Bifunctional System for Targeted Delivery of Therapeutic Membrane Impermeable Proteins to Tumors and Imaging of Cancer Therapy.” Molecular Pharmaceutics 7 (4): 1209–1222. doi:10.1021/mp100043h.
   PubMed Web of Science ®Google Scholar
• Schleich, N., C. Po, D. Jacobs, B. Ucakar, B. Gallez, F. Danhier, and V. Préat. 2014. “Comparison of Active, Passive and Magnetic Targeting to Tumors of Multifunctional Paclitaxel/SPIO-loaded Nanoparticles for Tumor Imaging and Therapy.” Journal of Controlled Release 194: 82–91. doi:10.1016/j.jconrel.2014.07.059.
   PubMed Web of Science ®Google Scholar
• Shanehsazzadeh, S., M. A. Oghabian, F. J. Daha, M. Amanlou, and B. J. Allen. 2013. “Biodistribution of Ultra Small Superparamagnetic Iron Oxide Nanoparticles in BALB Mice.” Journal of Radioanalytical and Nuclear Chemistry 295 (2): 1517–1523. doi:10.1007/s10967-012-2173-4.
   Web of Science ®Google Scholar
• Simberg, D., J. H. Park, P. D. Karmali, W. M. Zhang, S. Merkulov, K. McCrae, S. N. Bhatia, M. Sailor, and E. Ruoslahti. 2009. “Differential Proteomics Analysis of the Surface Heterogeneity of Dextran Iron Oxide Nanoparticles and the Implications for Their in Vivo Clearance.” Biomaterials 30 (23–24): 3926–3933. doi:10.1016/j.biomaterials.2009.03.056.
   PubMed Web of Science ®Google Scholar
• Sonmez, E., E. Aydin, H. Turkez, E. Özbek, B. Togar, K. Meral, D. Çetin, I. Cacciatore, and S. A. Di. 2016. “Cytotoxicity and Genotoxicity of Iron Oxide Nanoparticles: An In Vitro Biosafety Study.” Archives of Biological Sciences 68 (1): 41–50. doi:10.2298/ABS141218006S.
   Web of Science ®Google Scholar
• Sun, T., Y. S. Zhang, B. Pang, D. C. Hyun, M. Yang, and Y. Xia. 2014. “Engineered Nanoparticles for Drug Delivery in Cancer Therapy.” Angewandte Chemie International Edition 53 (46): 12320–12364.
   PubMed Web of Science ®Google Scholar
• Sun, Y., L. Duan, Z. Guo, Y. DuanMu, M. Ma, L. Xu, Y. Zhang, and N. Gu. 2005. “An Improved Way to Prepare Superparamagnetic Magnetite-silica Core-shell Nanoparticles for Possible Biological Application.” Journal of Magnetism and Magnetic Materials 285 (1–2): 65–70. doi:10.1016/j.jmmm.2004.07.016.
   Web of Science ®Google Scholar
• Sun, Z., M. Worden, J. A. Thliveris, S. Hombach-Klonisch, T. Klonisch, J. Van Lierop, T. Hegmann, and D. W. Miller. 2016. “Biodistribution of Negatively Charged Iron Oxide Nanoparticles (IONPs) in Mice and Enhanced Brain Delivery Using Lysophosphatidic Acid (LPA).” Nanomedicine: Nanotechnology, Biology, and Medicine 12 (7): 1775–1784. doi:10.1016/j.nano.2016.04.008.
   PubMed Web of Science ®Google Scholar
• Thorek, D. L. J., A. K. Chen, J. Czupryna, and A. Tsourkas. 2006. “Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging.” Annals of Biomedical Engineering 34 (1): 23–38. doi:10.1007/s10439-005-9002-7.
   PubMed Web of Science ®Google Scholar
• Tietze, R., S. Lyer, S. Durr, T. Struffert, T. Engelhorn, M. Schwarz, E. Eckert., et al. 2013. “Efficient Drug-delivery Using Magnetic Nanoparticles–biodistribution and Therapeutic Effects in Tumour Bearing Rabbits.” Nanomedicine: Nanotechnology, Biology, and Medicine 9 (7): 961–971. doi:10.1016/j.nano.2013.05.001.
   PubMed Web of Science ®Google Scholar
• Tong, S., S. Hou, Z. Zheng, J. Zhou, and G. Bao. 2010. “Coating Optimization of Superparamagnetic Iron Oxide Nanoparticles for High T2 relaxivity.” Nano Letters 10: 4607–4613. doi:10.1021/nl102623x.
   PubMed Web of Science ®Google Scholar
• Veintemillas-Verdaguer, S., M. P. Morales, and S. J. Serna. 1998. “Continuous Production of γ-Fe O Ultrafine Powders by Laser Pyrolysis.” Materials Letters 35 (3–4): 227–231. doi:10.1016/S0167-577X(97)00251-6.
   Web of Science ®Google Scholar
• Veiseh, O., C. Sun, C. Fang, N. Bhattarai, J. Gunn, F. Kievit, K. Du., et al. 2009. “Specific Targeting of Brain Tumors with an Optical/magnetic Resonance Imaging Nanoprobe across the Blood-brain Barrier.” Cancer Research 69 (15): 6200–6207. doi:10.1158/0008-5472.CAN-09-1157.
   PubMed Web of Science ®Google Scholar
• Walter, A., C. Billotey, A. Garofalo, C. Ulhaq-Bouillet, C. Lefèvre, J. Taleb, S. Laurent., et al. 2014. “Mastering the Shape and Composition of Dendronized Iron Oxide Nanoparticles to Tailor Magnetic Resonance Imaging and Hyperthermia.” Chemistry of Materials 26 (18): 5252–5264. doi:10.1021/cm5019025.
   Web of Science ®Google Scholar
• Wan, J., X. Chen, Z. Wang, X. Yang, and Y. Qian. 2005. “A Soft-Template-Assisted Hydrothermal Approach to Single-crystal Fe3O4 Nanorods.” Journal of Crystal Growth 276 (3–4): 571–576. doi:10.1016/j.jcrysgro.2004.11.423.
   Web of Science ®Google Scholar
• Wang, H., Q. Mu, R. Revia, K. Wang, B. Tian, G. Lin, W. Lee, Y.-K. Hong, and M. Zhang. 2018. “Iron Oxide-carbon Core-shell Nanoparticles for Dual-modal Imaging-guided Photothermal Therapy.” Journal of Controlled Release 289: 70–78. doi:10.1016/j.jconrel.2018.09.022.
   PubMed Web of Science ®Google Scholar
• Wang, J., Y. Chen, B. Chen, J. Ding, G. Xia, C. Gao, J. Cheng., et al. 2010. “Pharmacokinetic Parameters and Tissue Distribution of Magnetic Fe(3)O(4) nanoparticles in mice.” International Journal of Nanomedicine 5: 861–866. doi:10.2147/IJN.S13662.
   PubMed Web of Science ®Google Scholar
• Wang, L., J. Huang, H. Chen, H. Wu, Y. Xu, Y. Li, H. Yi, Y. A. Wang, L. Yang, and H. Mao. 2017. “Exerting Enhanced Permeability and Retention Effect Driven Delivery by Ultrafine Iron Oxide Nanoparticles with T1-T2 Switchable Magnetic Resonance Imaging Contrast.” ACS Nano 11 (5): 4582–4592. doi:10.1021/acsnano.7b00038.
   PubMed Web of Science ®Google Scholar
• Wei, H., O. T. Bruns, M. G. Kaul, E. C. Hansen, M. Barch, A. Wiśniowska, O. Chen., et al. 2017. “Exceedingly Small Iron Oxide Nanoparticles as Positive MRI Contrast Agents.” Proceedings of the National Academy of Sciences 114 (9): 2325–2330. doi:10.1073/pnas.1620145114.
   PubMed Web of Science ®Google Scholar
• Wilhelm, S., A. J. Tavares, Q. Dai, S. Ohta, J. Audet, H. F. Dvorak, and W. C. W. Chan. 2016. “Analysis of Nanoparticle Delivery to Tumours.” Nature Reviews Materials 1: 1–12.
   Web of Science ®Google Scholar
• Wu, W., Q. He, and C. Jiang. 2008. “Magnetic Iron Oxide Nanoparticles: Synthesis and Surface Functionalization Strategies.” Nanoscale Research Letters 3 (11): 397–415. doi:10.1007/s11671-008-9174-9.
   PubMed Web of Science ®Google Scholar
• Wu, W., Z. Wu, T. Yu, C. Jiang, and W. S. Kim. 2015. “Recent Progress on Magnetic Iron Oxide Nanoparticles: Synthesis, Surface Functional Strategies and Biomedical Applications.” Science and Technology of Advanced Materials 16 (2): 023501. doi:10.1088/1468-6996/16/2/023501.
   PubMed Web of Science ®Google Scholar
• Xu, C., S. Shi, L. Feng, F. Chen, S. A. Graves, E. B. Ehlerding, S. Goel., et al. 2016. “Long Circulating Reduced Graphene Oxide–iron Oxide Nanoparticles for Efficient Tumor Targeting and Multimodality Imaging.” Nanoscale 8 (25): 12683–12692. doi:10.1039/C5NR09193D.
   PubMed Web of Science ®Google Scholar
• Yang, L., G. Guo, X. Y. Niu, and J. Liu. 2015. “Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme.” BioMed Research International. Article ID: 717530. doi:10.1155/2015/717530.
   PubMed Web of Science ®Google Scholar
• Yang, L., H. Kuang, W. Zhang, Z. P. Aguilar, Y. Xiong, W. Lai, H. Xu, and H. Wei. 2015. “Size Dependent Biodistribution and Toxicokinetics of Iron Oxide Magnetic Nanoparticles in Mice.” Nanoscale 7 (2): 625–636. doi:10.1039/C4NR05061D.
   PubMed Web of Science ®Google Scholar
• Yang, X., H. Hong, J. J. Grailer, I. J. Rowland, A. Javadi, S. A. Hurley, Y. Xiao., et al. 2011. “cRGD-functionalized, DOX-conjugated, and 64Cu-labeled Superparamagnetic Iron Oxide Nanoparticles for Targeted Anticancer Drug Delivery and PET/MR Imaging.” Biomaterials 32 (17): 4151–4160. doi:10.1016/j.biomaterials.2011.02.006.
   PubMed Web of Science ®Google Scholar
• Yu, J., W. Yin, X. Zheng, G. Tian, X. Zhang, T. Bao, X. Dong., et al. 2015. “Smart MoS2/Fe3O4 Nanotheranostic for Magnetically Targeted Photothermal Therapy Guided by Magnetic Resonance/Photoacoustic Imaging.” Theranostics 5 (9): 931–945. doi:10.7150/thno.11802.
   PubMed Web of Science ®Google Scholar
• Zadnik, P. L., C. A. Molina, R. Sarabia-Estrada, M. L. Groves, M. Wablbler, J. Mihalic, E. F. McCarthy, Z. L. Gokaslslan, R. Ivkov, and D. M. Sciubbbba. 2014. “Characterization of Intratumor Magnetic Nanoparticle Distribution and Heating in a Rat Model of Metastatic Spine Disease.” Journal of Neurosurgery: Spine 20: 740–750. doi:10.3171/2014.2.SPINE13142.
   PubMed Web of Science ®Google Scholar
• Zhao, Z., Z. Zhou, J. Bao, Z. Wang, J. Hu, X. Chi, K. Ni., et al. 2013. “Octapod Iron Oxide Nanoparticles as high-performance T2 Contrast Agents For Magnetic Resonance Imaging.” Nature Communications 4: 2266.doi:10.1038/ncomms3266.
   PubMed Web of Science ®Google Scholar
• Zhen, G., B. W. Muir, B. A. Moffat, P. Harbour, K. S. Murray, B. Moubaraki, K. Suzuki., et al. 2011. “Comparative Study of the Magnetic Behavior of Spherical and Cubic Superparamagnetic Iron Oxide Nanoparticles.” Journal of Physical Chemistry C 115 (2): 327–334. doi:10.1021/jp104953z.
   Web of Science ®Google Scholar
• Zhou, J., J. Zhang, and W. Gao. 2014. “Enhanced and Selective Delivery of Enzyme Therapy to 9L-glioma Tumor via Magnetic Targeting of PEG-Modified, β-glucosidase-Conjugated Iron Oxide Nanoparticles.” International Journal of Nanomedicine 9: 2905–2917.
   PubMed Web of Science ®Google Scholar
• Zolata, H., F. A. Davani, and H. Afarideh. 2015. “Synthesis, characterization and Theranostic Evaluation of Indium-111 Labeled Multifunctional Superparamagnetic Iron Oxide Nanoparticles.” Nuclear Medicine and Biology 42 (2): 164–170. doi:10.1016/j.nucmedbio.2014.09.007.
   PubMed Web of Science ®Google Scholar